J&J Has A Plan B If Gamechanger Single Dose Vaccine Disappoints

OWS Leader Predicts Success

 
• By Andrew McConaghie
J&J vaccine trial
J&J's single dose vaccine could be a gamechanger - but has to come close to the efficacy achieved by Moderna and Pfizer/BioNTech's products. • Source: Michael Ciaglo/Getty Images

More from Business

More from Scrip